HPV vaccine found safe in girls and women with autoimmune diseases

August 1, 2016, Wiley
Electron micrograph of a negatively stained human papilloma virus (HPV) which occurs in human warts. Credit: public domain

In a recent study of girls and women diagnosed with at least one autoimmune disease, vaccination against human papillomavirus (HPV) did not increase the risk of developing another autoimmune disease. In fact, being vaccinated was associated with a slightly reduced risk compared with not being vaccinated.

The study included all 70,265 girls and women between 10 and 30 years of age in Sweden in 2006 to 2010 diagnosed with an autoimmune disease.

Dr. Lisen Arnheim-Dahlstrom, senior author of the Journal of Internal Medicine study, noted that individuals with autoimmune disease are vulnerable to vaccine-preventable diseases.

Explore further: No serious adverse reactions to HPV vaccination

More information: Journal of Internal Medicine, DOI: 10.1111/joim.12535

Related Stories

No serious adverse reactions to HPV vaccination

October 9, 2013
Researchers at Karolinska Institutet in Sweden and their Danish colleagues have monitored HPV-vaccinated girls via patient data registries in order to examine the incidence of a wide range of diseases and thus determine if ...

Implementing HPV vaccinations at a young age is significant for vaccine effectiveness, study finds

March 13, 2013
The incidence of genital warts, or condylomata, declined by 93 per cent in girls given the HPV vaccine before the age of 14, according to a Swedish national registry study. The study was carried out by researchers at Karolinska ...

Three doses of HPV vaccine recommended against genital warts

February 11, 2014
Two doses of vaccine against human papillomavirus (HPV) provide good protection against genital warts, but three doses is better according to an extensive register study by researchers at Karolinska Institutet in Sweden. ...

HPV vaccine reduced cervical abnormalities in young women

July 4, 2016
Young women who received the human papillomavirus (HPV) vaccine through a school-based program had fewer cervical cell anomalies when screened for cervical cancer, found a new study in CMAJ (Canadian Medical Association Journal).

Vaccine has cut HPV infection rate in teen girls by two-thirds: study

February 22, 2016
(HealthDay)—Ten years of vaccinating against human papillomavirus (HPV) has cut infections from this cancer-causing virus by 64 percent among teen girls, U.S. health officials report.

Around a fifth of unvaccinated ethnic school girls think they don't need HPV jab

November 2, 2015
Around 20 per cent of girls from ethnic minority backgrounds are not being vaccinated against the Human Papilloma Virus (HPV) because they feel they don't need to have it, according to a Cancer Research UK survey presented ...

Recommended for you

A code for reprogramming immune sentinels

December 10, 2018
For the first time, a research team at Lund University in Sweden has successfully reprogrammed mouse and human skin cells into immune cells called dendritic cells. The process is quick and effective, representing a pioneering ...

Potential seen for tailoring treatment for acute myeloid leukemia

December 8, 2018
Advances in rapid screening of leukemia cells for drug susceptibility and resistance are bringing scientists closer to patient-tailored treatment for acute myeloid leukemia (AML).

Study may offer doctors a more effective way to treat neuroblastoma

December 7, 2018
A very large team of researchers, mostly from multiple institutions across Germany, has found what might be a better way to treat patients with neuroblastoma, a type of cancer. In their paper published in the journal Science, ...

Major breakthrough in quest for cancer vaccine

December 6, 2018
The idea of a cancer vaccine is something researchers have been working on for over 50 years, but until recently they were never able to prove exactly how such a vaccine would work.

'Chemo brain' caused by malfunction in three types of brain cells, study finds

December 6, 2018
More than half of cancer survivors suffer from cognitive impairment from chemotherapy that lingers for months or years after the cancer is gone. In a new study explaining the cellular mechanisms behind this condition, scientists ...

Scientists develop new technology for profiling unique genetic makeup of myeloma tumor cells

December 6, 2018
Cancer arises when cells lose control. Deciphering the "blueprint" of cancer cells—outlining how cancer cells hijack specific pathways for uncontrolled proliferation—will lead to more efficient ways to fight it. Joint ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.